Kerman University of Medical Sciences International Journal of Health Policy and Management 2322-5939 9 10 2020 10 01 Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand 439 447 3740 10.15171/ijhpm.2020.01 EN Waranya Rattanavipapong Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand Ritika Kapoor Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore Yot Teerawattananon Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore 0000-0003-2217-2930 Jos Luttjeboer Asc Academics, Groningen, The Netherlands Siobhan Botwright World Health Organization (WHO), Genève, Switzerland Rachel A. Archer Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand Birgitte Giersing World Health Organization (WHO), Genève, Switzerland Raymond C. W. Hutubessy World Health Organization (WHO), Genève, Switzerland Journal Article 2019 05 10 <span class="fontstyle0">Background</span><br /><span class="fontstyle2">The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance structures and accountable decision-making processes for immunization policy. While the existing literature informs vaccine adoption decisions in GAVI-eligible countries, this study attempts to address a gap in the literature by examining the policy process of a non-GAVI eligible country.<br /></span><br /> <br /><span class="fontstyle0">Methods</span><br /><span class="fontstyle2">A rotavirus vaccine (RVV) test case was used to compare the decision criteria made by the existing processes (Expanded Program on Immunization [EPI], and National List of Essential Medicines [NLEM]) for vaccine prioritization and the TSE-pilot model, using Thailand specific data.<br /></span><br /> <br /><span class="fontstyle0">Results</span><br /><span class="fontstyle2">The existing decision-making processes in Thailand and TSE were found to offer similar recommendations on the selection of a RVV product.<br /></span><br /> <br /><span class="fontstyle0">Conclusion</span><br /><span class="fontstyle2">The authors believe that TSE can provide a well-reasoned and step by step approach for countries, especially low- and middle-income countries (LMICs), to develop a systematic and transparent decision-making process for immunization policy.</span> https://www.ijhpm.com/article_3740_33ef701c8059391708f1c3ddbe9f1f81.pdf